LAUSR

Multiparametric (mp) MRI of the prostate is now recommended as the initial investigation method for men with suspected prostate cancer within both UK and international guidelines. Potential benefits of this pathway include: (a) reductions in the number of men requiring biopsy; (b) reductions in the diagnoses of indolent cancers unlikely to cause harm, minimizing treatment-related complications; (c) improved detection of clinically significant prostate cancers, particularly for patients with prior negative systematic biopsy; and (d) improved risk-stratification of diagnosed cancers owing to greater precision in tumour grade and volume determinations.